Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells  by Kuo, Min-Liang et al.
ELSEVIER Biochimica et Biophysica Acta 1317 (1996) 95-100 
BB. Biochi~ic~a 
et Biophysica A~ta 
Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in 
human leukemia cells 
Min-Liang Kuo a,*, Tze-Sing Huang b, Jen-Kun Lin c 
a Institute of Toxicology College of Medicine, National Taiwan UniversiO', Taipei, Taiwan 
Cancer Clinical Research Laboratory, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan 
Institute of Biochemistry, College of Medicine, National Taiwan Unicersity, Taipei, Taiwan 
Received 9 May 1996; accepted 23 May 1996 
Abstract 
Curcumin, widely used as a spice and coloring agent in food, possesses potent antioxidant, anti-inflammatory and anti-tumor 
promoting activities. In the present study, curcumin was found to induce apoptotic ell death in promyelocytic leukemia HL-60 cells at 
concentrations a low as 3.5 txg/ml. The apoptosis-inducing activity of curcumin appeared in a dose- and time-dependent manner. Flow 
cytometric analysis howed that the hypodiploid DNA peak of propidium iodide-stained nuclei appeared at 4 h after 7 txg/ml curcumin 
treatment. The apoptosis-inducing activity of curcumin was not affected by cycloheximide, actinomycin D, EGTA, W 7 (calmodulin 
inhibitor), sodium orthovanadate, or genistein. By contrast, an endonuclease inhibitor ZnSO 4 and proteinase inhibitor N-tosyl-L-lysine 
chloro-methyl ketone (TLCK) could markedly abrogate apoptosis induced by curcumin, whereas 12-O-tetradecanoylphorbol,13-acetate 
(TPA) had a partial effect. The antioxidants, N-acetyl-L-cysteine (NAC), L-ascorbic acid, alpha-tocopherol, catalase and superoxide 
dismutase, all effectively prevented curcumin-induced apoptosis. This result suggested that curcumin-induced cell death was mediated by 
reactive oxygen species. Immunoblot analysis howed that the level of the antiapoptotic protein Bcl-2 was decreased to 30% after 6 h 
treatment with curcumin, and was subsequently reduced to 20% by a further 6 h treatment. Furthermore, overexpression f bcl-2 in 
HL-60 cells resulted in a delay of curcumin-treated cells entering into apoptosis, suggesting that bcl-2 plays a crucial role in the early 
stage of curcumin-triggered apoptotic ell death. 
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1. Introduction 
Curcumin (diferuloylmethane) is a major active compo- 
nent of the food flavor, turmeric (Curcuma longa). Several 
studies in recent years have shown that curcumin is a 
potent inhibitor of the initiation and promotion of chemical 
carcinogen-induced tumor formation in animals [1-3]. Be- 
sides its anti-carcinogenic effects, curcumin exhibits re- 
markable anti-inflammatory and anti-oxidant properties in 
viva [4-6]. The pharmacological safety of curcumin is 
demonstrated by its consumption for centuries at levels of 
up to 100 mg/day by people in certain countries [4]. 
However, the mechanism underlying the diverse effects of 
curcumin is not fully understood. One possible molecular 
Abbreviations: TLCK = Nqosyl-L-lysine chloro-methyl ketone; TPA 
= 12-O-tetradecanoylphorbol-13-acetate; PTK = protein tyrosine kinase; 
PKC = protein kinase C; NAC = N-acetyl-L-cysteine 
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mechanism that has been suggested is that curcumin can 
suppress the phorbol ester-induced transcriptional factor 
C-jun/AP-1 [7]. Recently, Korutla and Kumar [8] showed 
that 10 txM curcumin is capable of inhibiting the intrinsic 
kinase activity of epidermal growth factor (EGF)receptor, 
leading to growth inhibition of A431 cells. This indicates 
that curcumin is probably a potent anti-tumor agent for 
some cancer cells. 
Apoptosis, a mode of cell death, plays a crucial role in 
embryonic development, metamorphosis, hormone-depen- 
dent atrophy, and tumor growth as a physiological event, 
regulating cell number and eliminating damaged cells 
[9,10]. Several studies have demonstrated that apoptosis 
may be involved in cell death induced by chemotherapeu- 
tic agents including cisplatin, camptothecin, amsacrine, 
etoposide, and teniposide [11-13]. There is accumulating 
evidence that the efficiency of anti-tumor agents is related 
to the intrinsic propensity of the target tumor cells to 
respond to these agents by apoptosis [13]. The present 
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study was designed to investigate the mechanism by which 
curcumin exerts apoptosis-induced activity in tumor cells. 
In addition, the role Bcl-2 plays in curcumin-induced 
apoptosis is also investigated. 
2. Materials and methods 
2,1. Cell culture and chemicals 
Curcumin, cycloheximide, N-acetylcysteine, zinc sul- 
fate and TLCK all obtained from Sigma Chemical Co. 
(Santa Ana, CA, USA). Superoxide dismutatase and cata- 
lase were purchased from Boehringer Mannheim Co., Ger- 
many. Human promyelocytic leukemia (HL-60), human 
chronic myeloid leukemia (K562) and human colon adeno- 
carcinoma (SW620) were obtained from American Type 
Culture Collection (Rockville, MD) These cells were cul- 
tured in RPMI 1640 medium supplemented with 10% 
FCS; Hep3B (human hepatocellular carcinoma) was main- 
tained in DMEM medium supplemented with 10% FCS. 
2.2. Electron microscopy 
Curcumin-treated and untreated cells (0.1% DMSO) 
were fixed with fixative containing 2% glutaraldehyde and 
2% paraformaldehyde in PBS for 15 min. Following sev- 
eral rinses in PBS, cells were postfixed in 1% osmium 
tetroxide, dehydrated in alcohol and embedded in Epon- 
Araldite mixture. The sections were cut and doubly stained 
with uranyl acetate and lead citrate before being examined 
in a Joel 2000 EXII electron microscope at 100 KV. 
2.3. DNA extraction and electrophoresis 
Cells (1 × 10 6) were treated with different concentra- 
tions of curcumin for 16 h or fixed concentration for 
varying exposures of time, then harvested and washed 
twice in ice-cold PBS, resuspended in 500 ~1 TE (10 mM 
Tris-HCl pH 7.6, 1 mM EDTA pH 8.0), and lysed in 500 
~1 lysis buffer (3% SDS, 50 mM Tris, pH 12.6) at room 
temperature for 10 min. DNA was extracted with phenol 
and chloroform before precipitation with 95% ethanol. 
DNA pellets were finally solubilized in TE buffer, and 
treated with RNase A for 40 min prior to 1.2% agarose gel 
electrophoresis. 
allowed to stand on ice for 15-30 min. Fluorescence 
emitted from the P.I-DNA complex was quantified after 
laser excitation of the fluorescent dye on a FACSsor flow 
cytometer (Becton-Dickinson). The effect of various mod- 
ulators on curcumin-triggered apoptosis was also examined 
and quantified by FACS analysis. 
2.5. Establishment ofHL60-Bcl-2 cells 
HL-60 cells constitutively expressing human bcl-2 
(HL60-Bcl-2 cells) were created by electroporation (model 
T800; BTX, San Diego, CA, USA) of HL-60 cells with 
bcl-2 expression vector, pCAj-bcl2 (a gift from Dr. S.-F., 
Yang of the Institute of Molecular Biology, Academic 
Sinica, Taiwan). The expression vector pCAj-bcl-2 that 
carrying the human Bcl-2 cDNA under control of the 
SV40 promoter/enhancer sequence was developed by 
Tsujimoto [14] and recently has been used in study on the 
drug resistance in ovarian cancer [15]. Briefly, cells were 
suspended in 1 ml Hepes-buffered saline containing phas- 
mid DNA, then received electric treatment with different 
conditions as follows, electric amplitude, 300-350 V; 
pulse width, 99 txs, and subsequently each population of 
cells was cultured in medium containing G418 (100 
txg/ml). The levels of Bcl-2 expression of each population 
of cells were examined by immunoblotting. Subsequently, 
a cell line HL-60-Bcl-2-350, which expressed the most 
abundant Bci-2 protein, was selected to perform the apop- 
tosis assay. 
2.6. Immunoblotting 
Cellular lysates were prepared as described previously 
[16]. A 50 Ixg sample of each lysate was subjected to 
electrophoresis on 10% SDS-polyacrylamide g ls for de- 
tection of Bc|-2. The samples were then electroblotted on 
nitrocellulose paper. After blocking, blots were incubated 
with anti-Bcl-2 (Santa Cruz, California, USA) antibody in 
PBST for 1 hour followed by two washes (15 min each) in 
PBST, and then incubated with horseradish peroxidase- 
conjugated goat anti-mouse IgG (Amersham, USA) for 30 
rain. After washing, blots were incubated for 1 minute 
with Western blotting reagent ECL (Amersham, USA), 
and chemilluminescence was detected by exposure of the 
filters to Kodak-X-Omat films for 30 s to 30 min. 
2.4. Flow cytometry analysis 3. Results 
At an indicated time (0, 4, 8 and 24 h), curcumin-treated 
or untreated cells were harvested and fixed in 75% ethanol 
at -20°C for at least 1 h. After centrifugation at800 rpm 
for 5 min at 4°C, cell pellets were resuspended in 0.5 ml of 
a buffer (0.5% Triton X-100/PBS and 0.05% RNase A), 
and incubated for 30 min. Finally, 0.5 ml of propidium 
iodide (PI) solution (50 p~g/ml) was added, and cells were 
Curcumin exhibited a remarkable cytotoxic effect on 
various cancer cells, including HeLa (cervical carcinoma), 
SW620 (colon cancer), MCF-7 (breast cancer), Hep 3B 
(hepatocarcinoma) K562 and HL-60 (leukemia) (Fig. 1). 
Among them, HL-60 cells seemed to be the most suscepti- 
ble to curcumin treatment, with an LCs0 of approx. 5 
txg/ml. To determine the mode of cell death induced by 
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Fig. 1. The relative cell survival of various kinds of cancer cells after 
curcumin treatment. Each type of cancer cells were seeded at 5 X 105 and 
viable cells numbers were determined 48 h after culturing in media 
containing without (0.1% DMSO, black bar) or with 5 txg/ml (white bar) 
or 10 I~g/ml (grey bar) of curcumin. Cell viability was determined by 
staining cells with trypan blue followed by counting the number of live 
cells. These are representative data of three separate xperiments. 
12345678 
Fig. 3. Agarose gel electrophoresis of DNA extracted from HL-60 cells 
exposed with various concentrations or fixed concentration for varying 
periods of time of curcumin. (A) HL-60 cells (1 X 106) were incubated 
with 0.1% DMSO (lane 1) or with 1.75 Ixg/ml (lane 2), 3.5 txg/ml (lane 
3), 7 ~g/ml  (lane 4), and 14 ixg/ml (lane 5) curcumin for 16 h; (B) 
HL-60 cells were incubated with 3.5 Izg/ml curcumin for 0 h (lane 1), 1 
h (lane 2), 2 h (lane 3), 3 h (lane 4), 4 h (lane 5), 8 h (lane 6), 12 h (lane 
7) and 16 h (lane 8). DNA was isolated and subjected to electrophoresis 
on 1.2% agarose gel as described Section 2. 
curcumin, HL-60 cells were treated with 5 I~g/ml cur- 
cumin and morphological alterations were subsequently 
examined via electron microscopy. Morphological changes 
characteristic of apoptosis were disappearance of mi- 
crovilli, cell shrinkage, chromatin condensation and ap- 
pearance of blebbing and many apoptotic bodies (Fig. 2). 
Agarose gel electrophoresis of curcumin-treated chromoso- 
mal DNA showed a ladder-like pattern of DNA fragments 
consisting of multiples of approx. 180-200 base pairs (Fig. 
3A and B). The apoptosis-inducing activity of curcumin 
was dose- and time-dependent, being observed at concen- 
tration as low as 3.5 p,g/ml (Fig. 3A). However, if the 
concentration was increased up to 14 Ixg/ml, chromoso- 
mal DNA appeared smearing rather than laddering, indicat- 
ing that the cells underwent necrotic ell death. An early 
DNA fragmentation was seen at 2-4 h after exposure to 
3.5 Ixg/ml curcumin (Fig. 3B). To further determine the 
degree of apoptosis, we employed flow cytometry to quan- 
Fig. 2. Morphology of curcumin-treated HL-60 leukemia cells. Cells treated with 7 p~g/ml curcumin for 24 h were fixed with 2% glutaraldehyde for 15 
min. Following several rinses in PBS, cells were postfixed and dehydrated as described in Section 2. (A) Control HL-60 cells exposed to 0.1% DMSO 
( X 2800). (B) HL-60 cells exposed to curcumin (7 l~g/ml) ( X 2800). 
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Table 1 
Effects of various modulators on the curcumin-induced apoptotic cell 
death 
Treatment Dose % Apoptosis 
DMSO 0.1% 5 
Curcumin 7 txg/mt 62 
+ Cycloheximide 1 Ixg/ml 68 
+ Actinomycin D 10 ng/ml  66 
+EGTA 1 mmol/ml  71 
+ W 7 20 ng /ml  60 
+Na3VO 4 20 txmol/ml 65 
+ Genistein 20 Ixmol/ml 68 
+ ZnSO 4 2 mmol/ml  15 
+TLCK 10 Ixmol/ml 23 
+TPA 50 ng/ml  50 
+ N-acetyl-L-cysteine 5 mmol/ml  12 
+ L-ascorbic acid 100 ixmol/ml 26 
+ Alpha-tocopherol 100 ixmol/ml 25 
+ Catalase 200 ixg/ml 18 
+ SOD 100 Ixg/ml 20 
HL-60 cells were pretreated for 16 h with previously determined noncyto- 
toxic doses of the agents and for a further 24 hrs with 7 ixg/ml curcumin. 
Apoptotic cells were quantitated by flow cytometry analysis of propidium 
iodide-stained samples, as described in Section 2. Data are averages of 
two independent experiments. 
tify the sub-G 1 peak (apoptotic peak). Fig. 4 shows that 
when HL-60 cells were exposed to 7 Ixg/ml curcumin for 
4, 8 and 24 h resulted in 35, 42 and 68% apoptosis, 
respectively. 
To determine the events involved in curcumin-induced 
apoptosis, we examined a number of agents of known 
biochemical activity for their capacity to interfere with the 
cell death process. For this purpose, HL-60 cells were 
pretreated for 16 h with previously determined noncyto- 
toxic doses of the specified agents and for a further 24 h 
with 7 txg/ml curcumin. Cells with apoptotic DNA were 
quantified in suspension by propidium-iodide staining and 
flow cytofluorimetry analysis. Table 1 shows that cyclo- 
heximide or actinomycin D (inhibitors of protein synthesis 
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Fig. 5. A. Effects of curcumin on the levels of Bcl-2 protein determined 
by immunoblotting. Cells were exposed to 7 Ixg/mL curcumin, and 
harvested at different ime periods as follows: (1) untreated cells; (2) 1 h 
of exposure; (3) 2 h of exposure; (4) 4 h of exposure; (5) 6 h of exposure; 
(6) 12 h of exposure. After treatment, equal amount (50 Ixg/lane) of each 
cell lysate was electrophoresed on SDS-PAGE under educing conditions, 
and blotted. B. Stable transfection of HL-60 cells with a bcl-2 expression 
vector. Cells received electric treatment with different conditions as 
described in Section 2. The levels of Bcl-2 protein of each population of 
cells, as indicated as follows: HL-60 NEO (lane 1), HL-60-Bcl-2-300 
(lane 2), HL-60-Bcl-2-350 (lane 3) and HL-60-Bcl-2-400 (lane 4) were 
determined by Western blotting. HL-60 NEO cells were established by 
electroporation with a control neo gene containing plasmid. 
and RNA transcription, respectively) could not affect the 
extent of apoptotic ells induced by curcumin. Deprivation 
of intracellular calcium by EGTA or addition of calmod- 
ulin inhibitor W-7 did not influence curcumin-induced 
apoptosis. Deregulation of phosphotyrosine (P-tyr) status 
by the protein tyrosine phosphatase inhibitor, sodium or- 
thovanadium, or the protein tyrosine kinase (PTK) in- 
hibitor, genistein, did not interfere with curcumin-mediated 
cell death. In contrast, an endonuclease inhibitor ZnSO 4 
and proteinase inhibitor TLCK could markedly abrogate 
apoptosis induced by curcumin, whereas TPA (activator of 
PKC) had a partial effect. The antioxidants, N-acetyl-L-cy- 
steine, L-ascorbic acid, alpha-tocopherol, catalase and su- 
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Fig. 4. DNA fluoresence histograms of PI-stained HL-60 cells in FL2-H. Cells were treated with 7 txg/ml of curcumin for varying periods of time. A, 0 h; 
B, 4 h; C, 8 h; D, 24 h. The values indicated in figure represent the percentage of apoptosis. Ap, apoptosis. 
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Fig. 6. Overexpression f Bcl-2 confers resistance to apoptosis mediated 
by curcumin. Cells transfected with bcl-2 expressing vector (HL-60-Bcl- 
2-350) or with control neo gene plasmid (HL-60 NEO), were exposed to 
7 ixg/ml curcumin for indicated time. Cells with apoptotic DNA were 
quantitated by propidium-iodide staining and flow cytofluorimetry analy- 
sis. Values shown are means from three separate xperiments; the stan- 
dard errors of mean values are marked by bars. 
peroxide dismutase, all effectively prevented curcumin-in- 
duced apoptosis. 
In an attempt o explore the role of Bcl-2 protein in 
curcumin-induced apoptosis, we examined the level of 
Bcl-2 protein in HL-60 cells after treatment with curcumin. 
Immunoblot analysis of Bcl-2 showed that the antiapop- 
totic protein was decreased to 30% after 6 h treatment of 
curcumin, and subsequently was reduced to 20% by further 
6 h treatment (Fig. 5A), as compared to control. To 
determine if deregulated expression of Bcl-2 modifies the 
susceptibility to death after curcumin exposure, a FACS 
analysis was performed on the HL-60-Bcl-2-350, a cell 
line that had been transduced with a bcl-2 expression 
plasmid, contained elevated levels of Bcl-2 protein (Fig. 
5B). Flow cytometric analysis of hypodiploid cells clearly 
demonstrated that, while bcl-2 overexpression delayed en- 
try into apoptosis, e.g., exposing HL-60 cells to 7 ixg/ml 
curcumin for 8 and 16 h resulted in 41% and 50% apop- 
totic cells, respectively. In contrast, greater than 85% of 
HL60-Bcl-2-350 cells were still viable after 16 h treatment 
with the same concentration of curcumin (Fig. 6). More- 
over, Bcl-2 did not influence the cell-cycle distribution of 
the residual viable cells (data not shown). However, there 
was no significant difference in apoptosis between HL-60 
and HL-60-Bcl-2-350 cells after 24 h exposure to cur- 
cumin. These results indicated that the Bcl-2 protein could 
prevent curcumin-induced apoptotic ell death during early 
exposure time. 
4. Discussion 
In the present study we demonstrated that the dietary 
component curcumin induce apoptosis in human leukemia 
HL-60 cells at the very low concentration of 3.5 Ixg/ml. 
In addition, the cell death did not occur at a specific phase 
of cell cycle and as early as 4 h exposure to curcumin 
resulted in easily detectable chromatin DNA fragmenta- 
tion. Neither cycloheximide nor actinomycin D could ef- 
fect curcumin-induced cell death, slxggesting that the cell 
death process did not require new gene products. Cur- 
cumin has been shown to inhibit protein kinase C (PKC) 
[17] and protein tyrosine kinase (PTK) [8] activity in 
various cell systems. This led us to propose that apoptosis 
by curcumin may be through means of modulating both 
kinases. However, neither increasing p-tyr level by ortho- 
vanadate nor activation of PKC by TPA prevented the 
apoptotic cell death, thereby suggesting that PKC and 
PTK-associated pathways are not involved in curcumin-in- 
duced apoptosis. Although calcium- or calmodulin-depen- 
dent pathway has been reported to be related to antioxidant 
gallic acid-mediated apoptosis [18], we did not find the 
same mechanism was involved in curcumin induced cell 
death. 
Several observations indicate that oxidative stress is an 
important mediator of apoptosis. For instance, ionizing and 
ultraviolet radiation, low concentration of H202, and cer- 
tain cytokines stimulate apoptosis and generate reactive 
oxygen intermediates (ROIs) [19]. On the other hand, 
antioxidants, uch as gallic acid and all-trans retinoic acid, 
also induced apoptosis in different cell lines by generation 
of oxidative stress [18,20]. We show here that the antioxi- 
dant curcumin-induced cell death can be suppressed by 
some well-known scavengers of ROIs. This strongly im- 
plies that oxidative injury may play a pivitol role in 
curcumin-elicited apoptotic ell death. Considering some 
important cellular enzymes, e.g., PTK and PKC, were 
effectively inhibited by curcumin, it is therefore relevant 
that antioxidant enzymes uch as, superoxide dismutase or 
catalase, might also be interfered by curcumin, and this 
interference may subsequently result in an elevation of 
ROIs within target cells. However, the exact mechanism 
by which curcumin induce ROIs is completely unknown 
and remains to be investigated. 
Gene transfer studies in several types of mammalian 
cells have shown that elevations in Bcl-2 protein levels can 
protect cells from death induced by a wide variety of 
diverse insults and stimuli, suggesting that Bcl-2 controls a 
distal step in what may represent a final common pathway 
for apoptotic ell death [21]. Moreover, recent data support 
a role for Bcl-2 in an antioxidant pathway, whereby this 
protein prevents cell death by decreasing the formation of 
ROIs and lipid peroxidation. Here we found that Bcl-2 
proteins can be decreased ramatically by 6 h treatment 
with curcumin. But, the levels of mRNA did not change 
during the treatment of curcumin (data not shown). This 
suggests that curcumin regulates the Bcl-2 expression at a 
postranslational level. An interesting result presented here 
demonstrates that TLCK, a protease inhibitor, significantly 
abolished curcumin-triggered cell death. This raises a pos- 
sibility that the protection by TLCK may be through 
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stabilizing the Bcl-2 proteins via inhibiting some novel 
proteases. Furthermore, gene transfer study provided con- 
vincing evidences that elevation of Bcl-2 protein indeed 
delayed apoptosis in curcumin-treated HL-60 cells. Taken 
together, these findings suggest hat Bcl-2 proteins play a 
prominent role in curcumin-induced apoptotic ell death. 
The chemoprevention f cancer with curcumin has been 
intensively investigated [1-3]. In the present study we first 
demonstrated that curcumin exhibited pronounced anti- 
tumor activity by triggering apoptosis in human tumor 
cells. Recently, it becomes clearly that suppression of 
apoptosis by tumor promoting agents in preneoplastic cells 
is thought as an important mechanism for tumor promotion 
[22]. Supportive of this notion, a considerable incidence of 
apoptosis associated with remodeling has been observed in 
nodular lesions during their disappearance induced by 
administration of chemopreventive agent, S-adenosyl-L- 
methionine [23]. Thus, we suggest that the anti-tumor 
promoting effects of curcumin may be, at least in part, 
contributed by its apoptosis-inducing activity. Finally, the 
experiments reported here provide another evidence that 
curcumin may prove to be of therapeutic value in the 
treatment of human myeloid leukemia. 
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